Synexus changes PE hands; AstraZeneca taps BioData;

> U.K. CRO Synexus has changed hands, going to LDC for $128 million. More

> AstraZeneca ($AZN) has tapped contractor BioData to help track materials in its preclinical research sites. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.